Research Tracker›Biomarker Atlas›Gulf War Illness›Tumor Necrosis Factor-α (TNF-α)

Tumor Necrosis Factor-α (TNF-α) in Gulf War Illness

In Gulf War Illness (GWI, Gulf War Syndrome), published studies report higher levels of Tumor Necrosis Factor-α (TNF-α), also described as Pro-inflammatory cytokine, than in healthy Gulf War veteran controls. Clinically, it has been associated with fatigue, pain, inflammation. The evidence summarised here comes from Johnson et al. 2016 and reflects averages across cohorts rather than any single patient's result.

↑ ElevatedInflammatoryLOINC 3074-2

Summary

Direction in Gulf War Illness↑ Elevated — higher than in the comparison group
CategoryInflammatory
Also described asPro-inflammatory cytokine
Compared againstHGV (healthy Gulf War veteran controls)
Associated symptomsFatigue, pain, inflammation
Test typeBlood test (serum / plasma / whole blood)
LOINC code3074-2
SourceJohnson et al. 2016 — doi:10.1371/journal.pone.0157855
Condition atlasGulf War Illness Biomarker Atlas

Other conditions where Tumor Necrosis Factor-α (TNF-α) is reported

Atlas entryDirectionCompared against
Tumor Necrosis Factor-α (TNF-α) in Long COVID↑ elevatedvs HC, R
TNF-alpha in Low Back Pain↑ elevatedvs patients without micro-damaged CEPs
TNF-alpha in Major Depressive Disorder↑ elevatedvs healthy controls
Tumor Necrosis Factor-α (TNF-α) in ME/CFS↕ inconsistentvs HC

See the cross-condition hub: Tumor Necrosis Factor-α (TNF-α) across conditions.

Trials, interventions and tests

In clinical-trial registrations this marker maps to the outcome term Tumor Necrosis Factor-alpha (TNF-α) (10 registered trials use a matching outcome measure).

Clinical trials using Tumor Necrosis Factor-α (TNF-α) as an outcome

NCT07278206Recruiting
Brain Stimulation in Long COVID
Outcome measure: Tumor Necrosis Factor-alpha (TNF-α)
NCT07285707Recruiting
Acupuncture and Chinese Herbal Medicine for Long COVID
Outcome measure: Change in Laboratory Biomarkers - Tumor necrosis factor-alpha
NCT06073002Active Not Recruiting
Effects of a Home-Based Exercise Intervention in Subjects with Long COVID
Outcome measure: Change of tumor necrosis factor alpha (TNF-α measured in pg/ml)
NCT05848518Completed
Exercise for Health in Patients With Post-acute Sequelae of COVID-19
Outcome measure: Concentration of biomarkers of inflammation: Tumor necrosis factor
NCT05204511Completed
Exercise and Post-COVID/ Long-COVID: Effects of Different Training Modalities on Various Parameters in People Affected by the Sequelae of COVID-19
Outcome measure: Change of tumor necrosis factor alpha (TNF-α measured in pg/ml)
NCT06064838Completed
Effects of Cacao Flavonoids in Long COVID-19 Patients (FLALOC)
Outcome measure: TNF-alpha
Non-pharmacological and TCM-based Treatment for Long COVID Symptoms
Outcome measure: Neurobiological outcomes
NCT06211062Recruiting
The Use of Directed Probiotics in ME/CFS: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Outcome measure: The pro-inflammatory cytokines level e.g. IL-1, IL-6, and TNF-α

2 more trials reference this marker.

Interventions studied alongside this marker

Hypothesis-generating links from trial outcome usage and literature co-occurrence. Not treatment recommendations.

Commercial test availability

Tumor Necrosis Factor-α (TNF-α) — commercial laboratory test. Often send-out; availability varies by region.

Links are for reference only; availability, specimen requirements and coverage vary by location.

Related Inflammatory markers in Gulf War Illness

Full list: Gulf War Illness Biomarker Atlas.

Frequently asked questions

Is Tumor Necrosis Factor-α (TNF-α) high or low in Gulf War Illness?

Elevated. Studies summarised in the OSMF atlas report higher Tumor Necrosis Factor-α (TNF-α) in Gulf War Illness than in healthy Gulf War veteran controls. Source: Johnson et al. 2016.

What symptoms is Tumor Necrosis Factor-α (TNF-α) associated with in Gulf War Illness?

The cited literature associates this marker with Fatigue, pain, inflammation. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures Tumor Necrosis Factor-α (TNF-α)?

It is measured as a blood test (serum / plasma / whole blood). The standard laboratory code is LOINC 3074-2. Commercial laboratories such as Quest Diagnostics, LabCorp list an orderable assay.

Is one abnormal Tumor Necrosis Factor-α (TNF-α) result diagnostic of Gulf War Illness?

No. No single biomarker is diagnostic of Gulf War Illness. Tumor Necrosis Factor-α (TNF-α) findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Is Tumor Necrosis Factor-α (TNF-α) specific to Gulf War Illness?

No. The same marker is also reported in Long COVID, Low Back Pain, ME/CFS, Major Depressive Disorder in this atlas, so it reflects shared biology (for example inflammation or vascular stress) rather than a condition-specific signature.

Cite this page

Open Source Medicine Foundation. (2026). Tumor Necrosis Factor-α (TNF-α) in Gulf War Illness: direction, evidence and what it means. OSMF Research Tracker. Retrieved November 21, 2026, from https://research.opensourcemed.info/biomarkers/gulf-war-illness/tumor-necrosis-factor-alpha-tnf-alpha.html

Last reviewed: 2026-06-29 · Page generated from gulf-war-illness.json · Browse: Gulf War Illness atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.